Showing results (791-800 of 922) with videos related to
Sort By:
Pageof 93
The New England Journal of Medicine|July 21, 2006
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention ProgramJose C Florez, Kathleen A Jablonski, Nick Bayley, et al.Journal of Neurosurgery|May 10, 2022
Decompressive hemicraniectomy and cranioplasty using subcutaneously preserved autologous bone flaps versus synthetic implants: perioperative outcomes and cost analysisEhsan Dowlati, Kory B Dylan Pasko, Esteban A Molina, et al.Genitourinary Medicine|December 1, 1994
A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminataD K Armstrong, R D Maw, W W Dinsmore, et al.Diabetes|March 29, 2005
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention ProgramWilliam C Knowler, Richard F Hamman, Sharon L Edelstein, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 17, 2008
Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemiaBenjamin G Hassid, M Nathan Nair, Andrew F Ducruet, et al.Metabolism: Clinical and Experimental|October 23, 2009
The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humansMarie-France Hivert, Lisa M Sullivan, Peter Shrader, et al.The Journal of Clinical Endocrinology and Metabolism|January 11, 2007
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazoneJose C Florez, Kathleen A Jablonski, Maria W Sun, et al.JAMA Pediatrics|February 6, 2013
The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trialAaron S Kelly, Kyle D Rudser, Brandon M Nathan, et al.Multiple Sclerosis and Related Disorders|July 15, 2023
The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchersGuillaume Brocard, Romain Casey, Nathalie Dufay, et al.Diabetologia|October 11, 2025
Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes StudyWei Perng, Shiyu Shu, David M Nathan, et al.Pageof 93